investment.com

Alkermes plc. — insider transactions

22 transactions on record · ALKS · CIK 1520262

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
22
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
7
Bought, 3m
$0
Sold, 3m
$713.6K
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$2.2M
2026-08-03
Director share, 12m
40.9%
of transactions where role is stated
Current run
22 sells
consecutive same-direction transactions
Net 3m flow
-$713.6K
purchases minus sales
Total on record
22

Transactions

22 most recent shown
DisclosedRecorded (UTC)TradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-11-032026-11-04 03:34:34.777 UTC2026-11-030Gaffin David JosephEVP, CLO, Alkermes, Inc.Open market sale2,035$46.17$94Kfiling
2026-10-092026-10-10 02:37:18.487 UTC2026-10-072Whitaker Anne ClemDirectorGrant or award17,998$0.00—filing
2026-10-092026-10-10 02:37:18.592 UTC2026-10-081Reed JoshuaSVP, Chief Financial OfficerExercise of derivative9,164——filing
2026-10-092026-10-10 02:37:18.487 UTC2026-10-072Whitaker Anne ClemDirectorGrant or award7,239$0.00—filing
2026-10-092026-10-10 02:37:18.592 UTC2026-10-081Reed JoshuaSVP, Chief Financial OfficerShares withheld for tax4,069$40.11$163.2Kfiling
2026-10-092026-10-10 02:37:18.592 UTC2026-10-081Reed JoshuaSVP, Chief Financial OfficerExercise of derivative9,164——filing
2026-10-022026-10-03 02:23:07.178 UTC2026-10-020Gaffin David JosephEVP, CLO, Alkermes, Inc.Open market sale2,034$41.03$83.5Kfiling
2026-08-172026-08-18 02:30:33.410 UTC2026-08-170Nichols Christian ToddSVP, Chief Commercial OfficerOpen market sale664$49.65$33Kfiling
2026-08-172026-08-18 02:30:33.410 UTC2026-08-170Nichols Christian ToddSVP, Chief Commercial OfficerOpen market sale6,912$49.19$340Kfiling
2026-08-072026-08-08 03:18:38.777 UTC2026-08-052Jackson Blair CurtisDirector, CEO, Alkermes plcGrant or award93,229$0.00—filing
2026-08-072026-08-08 03:18:38.777 UTC2026-08-052Jackson Blair CurtisDirector, CEO, Alkermes plcGrant or award124,305$0.00—filing
2026-08-032026-08-04 02:23:16.709 UTC2026-08-030Hopkinson Craig C.EVP R&D, Chief Medical OfficerExercise of derivative4,896$24.59$120.4Kfiling
2026-08-032026-08-04 02:23:16.909 UTC2026-08-030snyderman nancy lynn MDDirectorExercise of derivative27,948$0.00—filing
2026-08-032026-08-04 02:23:16.709 UTC2026-08-030Hopkinson Craig C.EVP R&D, Chief Medical OfficerExercise of derivative104$19.34$2Kfiling
2026-08-032026-08-04 02:23:16.709 UTC2026-08-030Hopkinson Craig C.EVP R&D, Chief Medical OfficerExercise of derivative4,896$0.00—filing
2026-08-032026-08-04 02:23:16.909 UTC2026-08-030snyderman nancy lynn MDDirectorOpen market sale44,472$50.35$2.2Mfiling
2026-08-032026-08-04 02:23:16.509 UTC2026-08-030Gaffin David JosephEVP, CLO, Alkermes, Inc.Open market sale2,034$48.58$98.8Kfiling
2026-08-032026-08-04 02:23:16.709 UTC2026-08-030Hopkinson Craig C.EVP R&D, Chief Medical OfficerOpen market sale9,000$48.58$437.2Kfiling
2026-08-032026-08-04 02:23:16.709 UTC2026-08-030Hopkinson Craig C.EVP R&D, Chief Medical OfficerExercise of derivative104$0.00—filing
2026-08-032026-08-04 02:23:16.909 UTC2026-08-030snyderman nancy lynn MDDirectorExercise of derivative27,948$46.72$1.3Mfiling
2026-08-032026-08-04 02:23:16.909 UTC2026-08-030snyderman nancy lynn MDDirectorExercise of derivative16,524$46.72$772Kfiling
2026-08-032026-08-04 02:23:16.909 UTC2026-08-030snyderman nancy lynn MDDirectorExercise of derivative16,524$0.00—filing

Source: U.S. Securities and Exchange Commission, EDGAR

Privacy controls

We use essential cookies for sign-in, security and saved features. Recent-search history and performance analytics are optional and off until you choose.

Read our privacy policy